4.7 Review

Machine learning in predicting antimicrobial resistance: a systematic review and meta-analysis

期刊

出版社

ELSEVIER
DOI: 10.1016/j.ijantimicag.2022.106684

关键词

Antimicrobial; Resistance; Machine learning; Risk score; Prediction

向作者/读者索取更多资源

Machine learning may be a potential technology for predicting antimicrobial resistance, but limitations in the retrospective methodology for model development, nonstandard data processing, and scarcity of validation in randomized controlled trials or real-world studies restrict the application of these models in clinical practice.
Introduction: Antimicrobial resistance (AMR) is a global health threat; rapid and timely identification of AMR improves patient prognosis and reduces inappropriate antibiotic use.Methods: Relevant literature in PubMed, Web of Science, Embase and Institute of Electrical and Electron-ics Engineers prior to 28 September 2021 was searched. Any study that deployed machine learning (ML) or a risk score as a tool to predict AMR was included in the final review; there were 25 studies that employed the ML algorithm to predict AMR.Results: Extended spectrum beta-lactamases, methicillin-resistant Staphylococcus aureus (MRSA) and car-bapenem resistance were the most common outcomes in studies with a specific resistance pattern. The most common algorithms in ML prediction were logistic regression ( n = 14 studies), decision tree ( n = 14) and random forest ( n = 7). The area under the curve (AUC) range for ML prediction was 0.48- 0.93. The pooled AUC for ML prediction was 0.82 (0.78-0.85). Compared with risk score, higher specificity [87% (82-91) vs. 37% (25-51)] was indicated for ML prediction, but not sensitivity [67% (62-72) vs. 73% (67-79)].Conclusions: Machine learning might be a potential technology for AMR prediction; however, retrospec-tive methodology for model development, nonstandard data processing and scarcity of validation in a randomised controlled trial or real-world study limit the application of these models in clinical practice.(c) 2022 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据